“…fact, HTLV-I reactivity has not been found in studies of Spanish patients with various he matological malignancies (including mycosis fungoides, T cell leukemias and lymphomas), subacute myelopathies and autoimmune dis orders [1,5], This is in accordance with the findings of other studies in Europe [6][7][8], which have not identified HTLV-1 seroreactivity in native patients with lymphoprolifér ative syndromes or neurological disease. Thus, HTLV-I infection m patients with neu rological or lymphoproliférative diseases in Spam are probably from, or have been to HTLV-I-endemic regions.…”